Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascular Mild Cognitive Impairment

NANot yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

March 30, 2026

Conditions
Vascular DementiaMild Cognitive Impairment
Interventions
DEVICE

Cerogrin

Participants in this arm will receive transcutaneous auricular vagus nerve stimulation using the Cerogrin device. This device non-invasively delivers electrical stimulation to the vagus nerve located on the outer ear, aiming to improve cognitive function.

DEVICE

Sham Device

Participants in this arm will use a sham device. This device is identical in appearance to the active Cerogrin device but delivers no electrical stimulation or therapeutic effect. The sham device serves as a control to compare outcomes with the active treatment group.

All Listed Sponsors
lead

Neurogrin Inc.

INDUSTRY

NCT07149038 - Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascular Mild Cognitive Impairment | Biotech Hunter | Biotech Hunter